Premium
If you don't measure it, you can't improve it: Success and shortcomings of genomic assays in early breast cancer
Author(s) -
Danciu Oana C.,
Chen Zhengjia,
Hoskins Kent F.
Publication year - 2020
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.32955
Subject(s) - medicine , breast cancer , stage (stratigraphy) , oncology , cancer , chemotherapy , measure (data warehouse) , bioinformatics , gynecology , data mining , biology , computer science , paleontology
The ability of genomic assays to increase the number of women with early‐stage, hormone‐dependent breast cancer who can safely avoid chemotherapy has been firmly established. However, more research is needed to optimize available assays for underrepresented populations and to improve the accuracy of genomically informed prognostic and predictive tests.